DE69434760D1 - Teilchenverabreichung von therapeutischen Mitteln im pulverisierten Zustand - Google Patents

Teilchenverabreichung von therapeutischen Mitteln im pulverisierten Zustand

Info

Publication number
DE69434760D1
DE69434760D1 DE69434760T DE69434760T DE69434760D1 DE 69434760 D1 DE69434760 D1 DE 69434760D1 DE 69434760 T DE69434760 T DE 69434760T DE 69434760 T DE69434760 T DE 69434760T DE 69434760 D1 DE69434760 D1 DE 69434760D1
Authority
DE
Germany
Prior art keywords
therapeutic agents
powdered state
particle administration
particles
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69434760T
Other languages
English (en)
Other versions
DE69434760T2 (de
Inventor
Brian John Bellhouse
David Francis Sarphie
John Christopher Greenford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Powderject Research Ltd
Original Assignee
Powderject Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939307459A external-priority patent/GB9307459D0/en
Priority claimed from GB939318407A external-priority patent/GB9318407D0/en
Priority claimed from GB939321356A external-priority patent/GB9321356D0/en
Priority claimed from GB939326069A external-priority patent/GB9326069D0/en
Application filed by Powderject Research Ltd filed Critical Powderject Research Ltd
Publication of DE69434760D1 publication Critical patent/DE69434760D1/de
Application granted granted Critical
Publication of DE69434760T2 publication Critical patent/DE69434760T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
    • A61M5/3015—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules for injecting a dose of particles in form of powdered drug, e.g. mounted on a rupturable membrane and accelerated by a gaseous shock wave or supersonic gas flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/04—Mechanical means, e.g. sonic waves, stretching forces, pressure or shear stimuli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • C12N15/895—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection using biolistic methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/42—Reducing noise
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum
DE69434760T 1993-04-08 1994-04-08 Teilchenverabreichung von therapeutischen Mitteln im pulverisierten Zustand Expired - Lifetime DE69434760T2 (de)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB939307459A GB9307459D0 (en) 1993-04-08 1993-04-08 Particle delivery apparatus
GB9307459 1993-04-08
GB9318407 1993-09-06
GB939318407A GB9318407D0 (en) 1993-09-06 1993-09-06 Particle delivery apparatus
GB939321356A GB9321356D0 (en) 1993-10-15 1993-10-15 Particle delivery apparatus
GB9321356 1993-10-15
GB939326069A GB9326069D0 (en) 1993-12-21 1993-12-21 Particle delivery apparatus
GB9326069 1993-12-21

Publications (2)

Publication Number Publication Date
DE69434760D1 true DE69434760D1 (de) 2006-07-20
DE69434760T2 DE69434760T2 (de) 2007-05-16

Family

ID=27451010

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69434760T Expired - Lifetime DE69434760T2 (de) 1993-04-08 1994-04-08 Teilchenverabreichung von therapeutischen Mitteln im pulverisierten Zustand
DE69401651T Expired - Lifetime DE69401651T2 (de) 1993-04-08 1994-04-08 Nadellose spritze unter anwendung eines gasstroms mit überschallgeschwindigkeit zur verabreichung von partikeln

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69401651T Expired - Lifetime DE69401651T2 (de) 1993-04-08 1994-04-08 Nadellose spritze unter anwendung eines gasstroms mit überschallgeschwindigkeit zur verabreichung von partikeln

Country Status (32)

Country Link
US (5) US5630796A (de)
EP (4) EP1637173B1 (de)
JP (4) JP3260375B2 (de)
KR (1) KR100332147B1 (de)
CN (1) CN1109102C (de)
AT (2) ATE329006T1 (de)
AU (1) AU674742B2 (de)
BG (1) BG61993B1 (de)
BR (1) BR9406455A (de)
CA (1) CA2159452C (de)
CZ (1) CZ290476B6 (de)
DE (2) DE69434760T2 (de)
DK (2) DK0693119T3 (de)
ES (2) ES2098131T3 (de)
FI (1) FI120671B (de)
GR (1) GR3022939T3 (de)
HK (1) HK1000351A1 (de)
HU (2) HU228144B1 (de)
LV (1) LV11833B (de)
NO (1) NO314570B1 (de)
NZ (1) NZ263606A (de)
OA (1) OA10234A (de)
PL (1) PL174974B1 (de)
PT (1) PT734737E (de)
RO (1) RO118569B1 (de)
RU (1) RU2129021C1 (de)
SI (2) SI0693119T1 (de)
SK (1) SK283855B6 (de)
TJ (1) TJ248B (de)
TW (2) TW360548B (de)
UA (1) UA41360C2 (de)
WO (1) WO1994024263A1 (de)

Families Citing this family (305)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW360548B (en) 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
NZ279995A (en) * 1994-01-21 1998-04-27 Powderject Vaccines Inc Gas driven gene delivery instrument with a conical exit nozzle and a cartridge with an arcuate, linear passage
US5899880A (en) * 1994-04-08 1999-05-04 Powderject Research Limited Needleless syringe using supersonic gas flow for particle delivery
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
PL184068B1 (pl) * 1994-08-04 2002-08-30 Quadrant Holdings Cambridge Kompozycja farmaceutyczna o wysokiej stabilności i sposób wytwarzania kompozycji farmaceutycznej o wysokiej stabilności
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
GB9416663D0 (en) * 1994-08-17 1994-10-12 Oxford Bioscience Limited Particle delivery
GB9426379D0 (en) 1994-12-23 1995-03-01 Oxford Biosciences Ltd Particle delivery
GB9502879D0 (en) * 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
US5766901A (en) * 1995-05-04 1998-06-16 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and method for delivering a nucleotide into cell nuclei
US6474369B2 (en) 1995-05-26 2002-11-05 Penjet Corporation Apparatus and method for delivering a lyophilized active with a needle-less injector
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
GB9515846D0 (en) * 1995-08-02 1995-10-04 Boc Group Plc Gas capsule
DE69628095T2 (de) 1995-08-02 2004-02-19 The Boc Group Plc, Windlesham Gaszuführvorrichtung
US6080130A (en) * 1998-11-14 2000-06-27 Castellano; Thomas P. Gas power source for a needle-less injector
US6013050A (en) * 1995-10-20 2000-01-11 Powderject Research Limited Particle delivery
GB9605690D0 (en) * 1996-03-19 1996-05-22 Oxford Biosciences Ltd Particle delivery
CA2257141C (en) * 1996-06-14 2006-11-28 Powderject Vaccines, Inc. Sample delivery module for particle acceleration apparatus
US6893664B1 (en) 1996-06-17 2005-05-17 Powderject Research Limited Particle delivery techniques
KR100376646B1 (ko) 1996-07-01 2003-03-15 파마시아 에이비 전달 장치 및 이것의 작동 방법
CA2209406C (en) 1996-07-24 2007-05-15 David W. Birch Gas capsule and gas delivery system
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
DE19701494A1 (de) * 1997-01-17 1998-07-23 Boehringer Mannheim Gmbh Transdermales Injektionssystem
US5947928A (en) * 1997-06-19 1999-09-07 Mile Creek Capital, Llc Drug delivery system
EP0888790A1 (de) * 1997-07-04 1999-01-07 PowderJect Research Limited Vorrichtung zur Abgabe von Medikamententeilchen
EP0888791A1 (de) * 1997-07-04 1999-01-07 PowderJect Research Limited Spritze und dafür geeignete Medikamentenkapsel
US6074360A (en) * 1997-07-21 2000-06-13 Boehringer Mannheim Gmbh Electromagnetic transdermal injection device and methods related thereto
US6171276B1 (en) 1997-08-06 2001-01-09 Pharmacia & Upjohn Ab Automated delivery device and method for its operation
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
DE19820172A1 (de) * 1997-09-30 2005-01-27 Wolfgang Wagner Einrichtung und einrichtungsbezogenes Verfahren zur Einbringung eines Diagnostikträgers oder einer Arznei unter die Haut eines Lebewesens
ES2198780T3 (es) * 1997-11-20 2004-02-01 Aventis Pasteur Un metodo para administrar adn in vivo usando un aparato sin agujas.
CN1285753A (zh) * 1997-12-02 2001-02-28 鲍德杰克特疫苗公司 透皮给药微粒疫苗组合物
AU1922999A (en) * 1997-12-16 1999-07-05 Baylor College Of Medicine Needle-free injection of formulated nucleic acid molecules
GB9802506D0 (en) 1998-02-05 1998-04-01 Boc Group Plc Needleless medical device
GB9802508D0 (en) * 1998-02-05 1998-04-01 Boc Group Plc Needleless medical device
US6693087B1 (en) 1998-08-20 2004-02-17 Aventis Pasteur Limited Nucleic acid molecules encoding POMP91A protein of Chlamydia
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
EP1105490A1 (de) 1998-08-20 2001-06-13 Aventis Pasteur Limited Einschlussmembranprotein c von chlamydia kodierende nukleinsäuremoleküle
GB9818627D0 (en) * 1998-08-26 1998-10-21 Glaxo Group Ltd Improvements in dva vaccination
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
JP2002524741A (ja) * 1998-09-04 2002-08-06 パウダージェクト リサーチ リミテッド 粒子送達方法を使用する免疫診断
US6602678B2 (en) 1998-09-04 2003-08-05 Powderject Research Limited Non- or minimally invasive monitoring methods
EP1107690B1 (de) 1998-09-04 2003-04-16 PowderJect Research Limited Zweite medizinische indikation einer partikelverabreichungsmethode
USD434848S (en) * 1998-09-08 2000-12-05 Powderject Research Limited Disposable injector
PT1117382E (pt) 1998-10-01 2005-08-31 Powderject Res Ltd Microparticulas revestidas por pulverizacao para utilizacao em seringas sem agulha
DE69930294T2 (de) * 1998-10-19 2006-11-02 Powderject Vaccines, Inc., Madison Minimale promotoren und ihre verwendung
FR2785293B1 (fr) 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
US6264629B1 (en) 1998-11-18 2001-07-24 Bioject, Inc. Single-use needle-less hypodermic jet injection apparatus and method
GB9825763D0 (en) * 1998-11-25 1999-01-20 Boc Group Plc Filling containers with gas
WO2000043058A1 (en) * 1999-01-22 2000-07-27 Powderject Research Limited Method of enhancing needleless transdermal powdered drug delivery
US20070196490A1 (en) * 1999-01-22 2007-08-23 Powderject Research Limited Method of enhancing needleless transdermal powered drug delivery
US6849060B1 (en) * 1999-01-29 2005-02-01 Powderject Research Limited Particle delivery device
US6328714B1 (en) 1999-01-29 2001-12-11 Powderject Research Limited Particle delivery device
WO2000045792A1 (en) 1999-02-03 2000-08-10 Powderject Research Limited Hydrogel particle formulations
US7022320B1 (en) 1999-02-09 2006-04-04 Powderject Vaccines, Inc. Mycobacterium tuberculosis immunization
JP2002538195A (ja) * 1999-03-08 2002-11-12 パウダージェクト リサーチ リミテッド 生物活性化合物の持続放出用の無針注射器を使用する微粒子製剤の送達
US20050214227A1 (en) * 1999-03-08 2005-09-29 Powderject Research Limited Microparticle formulations for sustained-release of bioactive compounds
GB9905933D0 (en) * 1999-03-15 1999-05-05 Powderject Res Ltd Neeedleless syringe
US7013617B2 (en) 1999-04-01 2006-03-21 The Boc Group, Plc Method of filling and sealing
WO2000062759A1 (en) 1999-04-16 2000-10-26 Novo Nordisk A/S Dry, mouldable drug formulation
KR100702653B1 (ko) * 1999-04-16 2007-04-02 파우더젝트 리서치 리미티드 바늘없는 주사장치와 이로부터 입자를 배출하는 방법
US7060048B1 (en) * 1999-04-16 2006-06-13 Powerject Research Limited Needleless syringe
GB9916800D0 (en) * 1999-07-16 1999-09-22 Powderject Res Ltd Needleless syringe
FR2796288B1 (fr) * 1999-07-16 2001-08-10 Cross Site Technologies Seringue sans aiguille avec injecteur a elements emboites
FR2796290B1 (fr) * 1999-07-16 2001-09-14 Cross Site Technologies Seringue sans aiguille fonctionnant avec un generateur d'onde de choc a travers une paroi
US20050027239A1 (en) * 1999-08-20 2005-02-03 Stout Richard R. Intradermal injection system for injecting DNA-based injectables into humans
US6319224B1 (en) * 1999-08-20 2001-11-20 Bioject Medical Technologies Inc. Intradermal injection system for injecting DNA-based injectables into humans
US6811783B1 (en) 1999-09-07 2004-11-02 Aventis Pasteur Limited Immunogenic compositions for protection against chlamydial infection
DE19946059A1 (de) * 1999-09-25 2001-03-29 Roche Diagnostics Gmbh System zur transdermalen Gewinnung von Körperflüssigkeit
GB9923306D0 (en) 1999-10-01 1999-12-08 Isis Innovation Diagnostic and therapeutic epitope, and transgenic plant
US6626871B1 (en) 1999-10-11 2003-09-30 Felton International, Inc. Method and apparatus for removing cap from medical device
CA2721011A1 (en) 1999-10-22 2001-05-03 Aventis Pasteur Limited Modified gp100 and uses thereof
DK1142590T3 (da) * 1999-10-29 2009-01-26 Anges Mg Inc Genterapi til diabetisk iskæmisk sygdom
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US20040234539A1 (en) * 1999-11-03 2004-11-25 Powderject Research Limited Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression
FR2800619B1 (fr) * 1999-11-05 2002-02-08 Cross Site Technologies Seringue sans aiguille avec un moyen de poussee temporairement retenu
US20040109874A1 (en) * 1999-11-10 2004-06-10 Powderject Vaccines, Inc. Induction of mucosal immunity by vaccination via the skin route
US7029457B2 (en) 1999-11-23 2006-04-18 Felton International, Inc. Jet injector with hand piece
US6770054B1 (en) 1999-11-23 2004-08-03 Felton International, Inc. Injector assembly with driving means and locking means
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
FR2802102B1 (fr) 1999-12-08 2002-07-12 Poudres & Explosifs Ste Nale Seringue sans aiguille munie d'un tube d'ejection a section constante
FR2802103B1 (fr) 1999-12-08 2003-10-03 Poudres & Explosifs Ste Nale Seringue sans aiguille fonctionnant avec entrainement du principe actif par effet tube a choc
FR2802820B1 (fr) 1999-12-27 2002-10-18 Poudres & Explosifs Ste Nale Seringue sans aiguille fonctionnant par effet tube a choc, avec maintien prealable du principe actif sur le cote
FR2804329B1 (fr) 2000-02-02 2002-12-13 Poudres & Explosifs Ste Nale Seringue sans aiguille munie d'un opercule contenant le principe actif
US6689092B2 (en) 2000-03-03 2004-02-10 Boehringer International Gmbh Needle-less injector of miniature type
GB0006263D0 (en) * 2000-03-15 2000-05-03 Powderject Res Ltd Apparatus and method for adjusting the characteristics of a needleless syringe
US6716190B1 (en) * 2000-04-19 2004-04-06 Scimed Life Systems, Inc. Device and methods for the delivery and injection of therapeutic and diagnostic agents to a target site within a body
EP1792995A3 (de) 2000-05-08 2007-06-13 Sanofi Pasteur Limited Chlamydia Antigene, entsprechende DNS Fragmente und ihre Verwendungen
CA2408328C (en) 2000-05-10 2012-04-17 Aventis Pasteur Limited Immunogenic polypeptides encoded by mage minigenes and uses thereof
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AU2001268762A1 (en) * 2000-05-26 2001-12-03 George Vizirgianakis Treatment and therapy apparatus
US20040213798A1 (en) * 2000-06-08 2004-10-28 Powderject Vaccines, Inc. Spray-dried alum compositions
US7597692B2 (en) * 2000-06-08 2009-10-06 Massachusetts Institute Of Technology Microscission processes and procedures
EP1289494A2 (de) * 2000-06-08 2003-03-12 Powderject Vaccines, Inc. Pulverzusammensetzungen
US20020120228A1 (en) * 2000-06-08 2002-08-29 Yuh-Fun Maa Powder compositions
US6706032B2 (en) * 2000-06-08 2004-03-16 Massachusetts Institute Of Technology Localized molecular and ionic transport to and from tissues
GB0018035D0 (en) 2000-07-21 2000-09-13 Powderject Res Ltd Needleless syringe
US20020051821A1 (en) * 2000-09-08 2002-05-02 Sung-Yun Kwon Aliginate particle formulation
US6824822B2 (en) * 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
US6981660B2 (en) * 2000-09-25 2006-01-03 Evit Labs Shock wave aerosolization apparatus and method
AU2001294742A1 (en) * 2000-09-25 2002-04-02 Evit Laboratories, Inc. Shock wave aerosolization apparatus and method
GB0025147D0 (en) 2000-10-13 2000-11-29 Torsana Diabetes Diagnostics A Optical sensor for in situ measurement of analytes
EP1379273B1 (de) 2000-11-27 2009-09-16 Powderject Vaccines, Inc. Nukleinsäureadjuvantien
US7931614B2 (en) * 2000-11-30 2011-04-26 Valeritas, Inc. Injection systems
GB0100756D0 (en) * 2001-01-11 2001-02-21 Powderject Res Ltd Needleless syringe
US6443152B1 (en) 2001-01-12 2002-09-03 Becton Dickinson And Company Medicament respiratory delivery device
US6644309B2 (en) * 2001-01-12 2003-11-11 Becton, Dickinson And Company Medicament respiratory delivery device and method
US6722364B2 (en) * 2001-01-12 2004-04-20 Becton, Dickinson And Company Medicament inhalation delivery devices and methods for using the same
ES2191528B1 (es) * 2001-02-05 2004-06-16 Danone, S.A. Dispositivo para la dosificacion de substancias liquidas.
GB0103348D0 (en) * 2001-02-10 2001-03-28 Medical Res Council Delivery of biologically active agents
JP2004529754A (ja) 2001-03-14 2004-09-30 ペンジェット・コーポレーション 溶液から溶解ガスを除去するためのシステムおよび方法
AU2002252378B2 (en) 2001-03-19 2007-10-18 Intercell Usa, Inc. Transcutaneous immunostimulation
US20050192530A1 (en) * 2001-04-13 2005-09-01 Penjet Corporation Method and apparatus for needle-less injection with a degassed fluid
US6613010B2 (en) 2001-04-13 2003-09-02 Penjet Corporation Modular gas-pressured needle-less injector
WO2002087663A2 (en) 2001-04-27 2002-11-07 Penjet Corporation Method and apparatus for filling or refilling a needle-less injector
DE10121255A1 (de) * 2001-04-30 2002-11-07 Switch Biotech Ag Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
US6648850B2 (en) * 2001-06-08 2003-11-18 Bioject, Inc. Durable needle-less jet injector apparatus and method
EP1399131A2 (de) * 2001-06-08 2004-03-24 Powderject Vaccines, Inc. Sprüh- gefriergetrockneten zubereitungen
US20030019558A1 (en) * 2001-07-26 2003-01-30 Smith Edward R. Particle cassette, method and kit therefor
GB0118266D0 (en) 2001-07-26 2001-09-19 Powderject Res Ltd Silencing device and method for needleless syringe
PT1409045E (pt) * 2001-07-26 2009-05-18 Powderject Res Ltd Cassete de partículas, método e kit correspondentes
US8061006B2 (en) * 2001-07-26 2011-11-22 Powderject Research Limited Particle cassette, method and kit therefor
DE20112501U1 (de) * 2001-07-30 2002-12-19 Disetronic Licensing Ag Verriegelungssperre für eine Verbindung von Gehäuseteilen eines Injektions- oder Infusionsgeräts
DE10163325B4 (de) * 2001-07-30 2005-07-28 Tecpharma Licensing Ag Verriegelungssperre für eine Verbindung von Gehäuseabschnitten eines Verabreichungsgeräts
DE10163328B4 (de) * 2001-07-30 2005-08-11 Tecpharma Licensing Ag Verabreichungsgerät mit Verdrehsicherung
DE10163326A1 (de) * 2001-07-30 2003-02-27 Disetronic Licensing Ag Verabreichungsgerät mit Dosiervorrichtung
DE10163327A1 (de) 2001-07-30 2003-02-27 Disetronic Licensing Ag Reservoirmodul mit Kolbenstange
US20050191361A1 (en) * 2001-08-03 2005-09-01 Powederject Research Ltd. Hydrogel particle formation
US6824526B2 (en) 2001-10-22 2004-11-30 Penjet Corporation Engine and diffuser for use with a needle-less injector
AU2002366267B2 (en) * 2001-11-19 2007-05-10 Becton, Dickinson And Company Pharmaceutical compositions in particulate form
WO2003052125A1 (en) 2001-12-17 2003-06-26 Powderject Research Limited Non-or minimally invasive monitoring methods
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
JP2005514393A (ja) 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
DE20209051U1 (de) 2001-12-21 2003-04-24 Disetronic Licensing Ag Injektionsgerät mit endpositionsblockiertem Dosiseinstellglied
US20030130614A1 (en) * 2002-01-09 2003-07-10 Johnson Lanny L. Device for delivering liquid medications or nutrients and gases to local tissue
RU2279898C2 (ru) 2002-02-18 2006-07-20 Данфосс А/С Устройство для введения жидких лекарственных форм
US20030163111A1 (en) * 2002-02-26 2003-08-28 Daellenbach Keith K. End effector for needle-free injection system
CA2380671A1 (fr) * 2002-04-05 2003-10-05 Stephane Dufresne Seringue sans aiguille pour l'injection sous-cutanee de gouttelettes medicamenteuses
EP1356820A1 (de) 2002-04-26 2003-10-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) DNA-Impfstoff kombiniert mit einen Apoptoneauslöser von Tumorzellen
US7334580B2 (en) * 2002-05-07 2008-02-26 Smaldone Gerald C Methods, devices and formulations for targeted endobronchial therapy
US7607436B2 (en) * 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US7156823B2 (en) * 2002-06-04 2007-01-02 Bioject Inc. High workload needle-free injection system
GB0212885D0 (en) 2002-06-05 2002-07-17 Isis Innovation Therapeutic epitopes and uses thereof
NZ539107A (en) 2002-09-27 2008-11-28 Powderject Res Ltd Nucleic acid coated particles
CA2500713C (en) * 2002-10-04 2012-07-03 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
EP1444999B1 (de) * 2003-02-03 2010-07-21 BioWare Technology Co., Ltd Genpistole mit Niederdruckgasbeschleunigung
DE10306716A1 (de) * 2003-02-17 2004-09-02 Lell, Peter, Dr.-Ing. Vorrichtung zum Injizieren eines staub-oder pulverförmigen Stoffs in ein Gewebe eines Körpers
MXPA05010221A (es) * 2003-03-25 2006-02-22 Terry O Herndon Dispositivo y metodo de taladrado para formar microconductos.
DE10316237A1 (de) * 2003-04-09 2004-11-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Kanüle und Verfahren zur Einführung einer Kanüle in biologisches Material
JP2006524120A (ja) * 2003-04-21 2006-10-26 ストラテージェント ライフ サイエンシズ マイクロジェットで反復的に薬物を搬送する装置および方法
US20060184101A1 (en) * 2003-04-21 2006-08-17 Ravi Srinivasan Microjet devices and methods for drug delivery
WO2004110533A1 (ja) * 2003-05-09 2004-12-23 Anges Mg, Inc. 薬剤が収容された針無注射器
AU2004246870B2 (en) 2003-06-13 2009-07-23 Skendi Finance Ltd Slow release estradiol-progesterone formulation for contraception and hormone replacement therapy
US7131961B2 (en) * 2003-10-01 2006-11-07 Bioject, Inc. Needle-free injection system
AU2004279991B2 (en) * 2003-10-10 2010-11-25 Powderject Vaccines, Inc. Nucleic acid constructs
US7442182B2 (en) * 2003-10-24 2008-10-28 Bioject, Inc. Spring powered needle-free injection system
US8147426B2 (en) * 2003-12-31 2012-04-03 Nipro Diagnostics, Inc. Integrated diagnostic test system
US20050209554A1 (en) * 2004-03-19 2005-09-22 Sergio Landau Needle-free single-use cartridge and injection system
US20050209553A1 (en) * 2004-03-19 2005-09-22 Sergio Landau Needle-free single-use cartridge and injection system
JP4210231B2 (ja) * 2004-03-25 2009-01-14 株式会社資生堂 皮膚のシワを改善する美容方法及びシワ改善具
US7456254B2 (en) 2004-04-15 2008-11-25 Alkermes, Inc. Polymer-based sustained release device
US20060110423A1 (en) * 2004-04-15 2006-05-25 Wright Steven G Polymer-based sustained release device
CN1968700A (zh) * 2004-04-15 2007-05-23 阿尔克姆斯有限公司 聚合物基的持续释放装置
NZ550600A (en) 2004-04-28 2010-03-26 Btg Int Ltd Epitopes related to coeliac disease
US10105437B2 (en) 2004-04-28 2018-10-23 Btg International Limited Epitopes related to coeliac disease
EP1765294B1 (de) 2004-05-12 2008-09-24 Baxter International Inc. Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
WO2005112885A2 (en) 2004-05-12 2005-12-01 Baxter International Inc. Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
US7717874B2 (en) * 2004-05-28 2010-05-18 Bioject, Inc. Needle-free injection system
US20060038044A1 (en) * 2004-08-23 2006-02-23 Van Steenkiste Thomas H Replaceable throat insert for a kinetic spray nozzle
US20060089593A1 (en) * 2004-10-26 2006-04-27 Sergio Landau Needle-free injection device for individual users
US20060089594A1 (en) * 2004-10-26 2006-04-27 Sergio Landau Needle-free injection device
JP4904283B2 (ja) 2004-12-01 2012-03-28 アキュショット インク 無針注射器
JP2008526229A (ja) * 2005-01-06 2008-07-24 ベニテック，インコーポレーテッド 幹細胞の維持のためのＲＮＡｉ剤
GB0507997D0 (en) * 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006091459A2 (en) 2005-02-24 2006-08-31 Joslin Diabetes Center, Inc. Compositions and methods for treating vascular permeability
DE102005015801A1 (de) * 2005-04-06 2006-10-19 Schreiner Group Gmbh & Co. Kg Folienbasierter Schutzmechanismus
US20070118093A1 (en) * 2005-06-20 2007-05-24 Von Muhlen Marcio G High-speed jet devices for drug delivery
US20070055199A1 (en) * 2005-08-10 2007-03-08 Gilbert Scott J Drug delivery device for buccal and aural applications and other areas of the body difficult to access
CN101242869B (zh) 2005-09-02 2010-05-26 Iomai公司 经皮递送疫苗和透皮递送药物的装置及其应用
US8142391B2 (en) * 2005-11-29 2012-03-27 Mitchell Stuart B Electrostatic transcutaneous hypodermic spray (electrostatic hypospray)
JP4402648B2 (ja) 2005-12-16 2010-01-20 オリンパス株式会社 被検体内導入装置
US20080161755A1 (en) * 2006-01-27 2008-07-03 Bioject Inc. Needle-free injection device and priming system
RU2008129182A (ru) 2006-01-31 2010-03-10 Ново Нордиск А/С (DK) Изолирующий компонент для предварительно заполненного медицинского струйного инъектора
GB0611443D0 (en) * 2006-06-09 2006-07-19 Powderject Res Ltd Improvements in, or relating to, particle cassettes
KR101200728B1 (ko) 2006-08-09 2012-11-13 인타르시아 세라퓨틱스 인코포레이티드 삼투성 전달 시스템 및 피스톤 조립체
CN100446823C (zh) * 2006-09-19 2008-12-31 宁波新芝生物科技股份有限公司 一种无创介入治疗系统
US7547293B2 (en) 2006-10-06 2009-06-16 Bioject, Inc. Triggering mechanism for needle-free injector
EP2077821B1 (de) 2006-10-12 2019-08-14 The University Of Queensland Zusammensetzungen und verfahren zur modulierung von immunreaktionen
FR2908753B1 (fr) * 2006-11-16 2011-11-11 Becton Dickinson France Dispositif pour delivrer automatiquement des doses successives de produit
DE102007004855B4 (de) * 2007-01-31 2014-03-27 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Vorrichtung und Verfahren zur Deposition von biologischem Material in einem Zielsubstrat
JP2008199905A (ja) * 2007-02-16 2008-09-04 Snow Brand Milk Prod Co Ltd 乳酸菌生残性向上剤
WO2008103997A2 (en) * 2007-02-23 2008-08-28 Bioject Inc. Needle-free injection devices and drug delivery systems therefor
AU2008244523B2 (en) 2007-04-23 2012-02-16 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
GB0708758D0 (en) 2007-05-04 2007-06-13 Powderject Res Ltd Particle cassettes and process thereof
CN101754682B (zh) 2007-05-16 2014-11-12 布里格姆妇女医院 突触核蛋白病的治疗
GB2449312B (en) 2007-05-18 2012-03-14 Malvern Instr Ltd Method and apparatus for dispersing a sample of particulate material
JP4780034B2 (ja) * 2007-05-18 2011-09-28 株式会社島津製作所 針無注射器
PL2612868T3 (pl) 2007-11-01 2018-12-31 Astellas Pharma Inc. Immunosupresyjne polipeptydy i kwasy nukleinowe
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
US20110117673A1 (en) * 2008-07-16 2011-05-19 Johnson Brandon T Methods and systems to collect and prepare samples, to implement, initiate and perform assays, and to control and manage fluid flow
US8021873B2 (en) 2008-07-16 2011-09-20 Boston Microfluidics Portable, point-of-care, user-initiated fluidic assay methods and systems
US8658350B2 (en) 2008-09-22 2014-02-25 Oregon Health & Science University Methods for detecting Mycobacterium tuberculosis disease
DE102008048981A1 (de) * 2008-09-25 2010-04-15 Lts Lohmann Therapie-Systeme Ag Injektor und Zwei-Kammer-System mit sterilen Komponenten
US9207242B2 (en) 2008-10-09 2015-12-08 The University Of Hong Kong Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
US20100111857A1 (en) 2008-10-31 2010-05-06 Boyden Edward S Compositions and methods for surface abrasion with frozen particles
US8725420B2 (en) 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9050070B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US20100111834A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for therapeutic delivery with frozen particles
US8409376B2 (en) 2008-10-31 2013-04-02 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9072799B2 (en) 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9060934B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8731841B2 (en) * 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9072688B2 (en) * 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8793075B2 (en) 2008-10-31 2014-07-29 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9060926B2 (en) * 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8551505B2 (en) * 2008-10-31 2013-10-08 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8545855B2 (en) * 2008-10-31 2013-10-01 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8731840B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9050317B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8762067B2 (en) * 2008-10-31 2014-06-24 The Invention Science Fund I, Llc Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
US8788211B2 (en) * 2008-10-31 2014-07-22 The Invention Science Fund I, Llc Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
US8721583B2 (en) 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8232093B2 (en) 2009-02-05 2012-07-31 Indian Institute Of Science Apparatus and method for genetically transforming cells
EP2405961A4 (de) * 2009-03-09 2012-08-08 Purdue Research Foundation Kompakte vorrichtung für schnelle mischung und verabreichung von stoffen an einen patient
WO2010105096A2 (en) 2009-03-11 2010-09-16 University Of Massachusetts Modulation of human cytomegalovirus replication by micro-rna 132 (mir132), micro-rna 145 (mir145) and micro-rna 212 (mir212)
ES2548987T3 (es) 2009-03-27 2015-10-22 Christine Chomienne Ácido nucleico antisentido de kanamicina para el tratamiento del cáncer
EP2756845B1 (de) 2009-04-03 2017-03-15 Dicerna Pharmaceuticals, Inc. Verfahren und Zusammensetzungen für spezifische KRAS-Hemmung mit asymmetrischer Doppelstrang-RNA
GB0906215D0 (en) 2009-04-09 2009-05-20 Lalvani Ajit Diagnostic test
TWI439302B (zh) 2009-07-14 2014-06-01 Chien Lung Chen 傳輸裝置
CN101987218B (zh) * 2009-07-30 2013-07-10 陈建龙 传输装置
SI2462246T1 (en) 2009-09-28 2018-01-31 Intarcia Therapeutics, Inc. Fast-setting and / or cessation of substantially unchanged delivery of the product
US20120208750A1 (en) 2009-09-29 2012-08-16 Joslin Diabetes Center, Inc. Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
EP2501397B1 (de) 2009-11-20 2017-10-04 Oregon Health and Science University Verfahren zum hervorrufen einer immunantwort auf tuberkulose
WO2011063349A1 (en) * 2009-11-20 2011-05-26 Talima Therapeutics, Inc. Devices for implanting compositions and methods and kits therefor
CN201888971U (zh) * 2010-01-08 2011-07-06 江苏华兰米特医疗科技有限公司 无针注射器
US20130012916A1 (en) 2010-02-11 2013-01-10 Glide Pharmaceutical Technologies Limited Delivery of immunoglobulin variable domains and constructs thereof
CN101797411B (zh) * 2010-03-18 2011-12-07 傅雅芬 一种气压式无针注射器动力头
WO2011123762A1 (en) * 2010-04-01 2011-10-06 Glucago Llc Method and device for mixing substances
US8895017B2 (en) 2010-06-07 2014-11-25 Pfizer Inc. HER-2 peptides and vaccines
US8821434B2 (en) * 2010-10-07 2014-09-02 Massachusetts Institute Of Technology Delivery of a solid body and/or a fluid using a linear Lorentz-force actuated needle-free jet injection system
US9211378B2 (en) 2010-10-22 2015-12-15 Cequr Sa Methods and systems for dosing a medicament
CN103328499A (zh) 2010-11-01 2013-09-25 悉尼科技大学 免疫调节剂及其用途
GB201021881D0 (en) * 2010-12-23 2011-02-02 Profibrix Bv Powder delivery device
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US8430839B2 (en) 2011-04-19 2013-04-30 Palo Alto Research Center Incorporated Drug delivery devices and methods with collimated gas stream and drug reservoir
US8388569B2 (en) 2011-04-19 2013-03-05 Xerox Corporation Delivery devices and methods with collimated gas stream and particle source
US8486002B2 (en) 2011-04-19 2013-07-16 Palo Alto Research Center Incorporated Drug delivery devices and methods with collimated gas stream and release-activatable tape
WO2013037804A1 (en) 2011-09-12 2013-03-21 Laboratorios Del Dr. Esteve, S.A. Method for monitoring cytotoxic t lymphocyte (ctl) responses by a delayed-type hypersensitivity reaction using defined ctl viral epitopes
JP2014533953A (ja) 2011-11-17 2014-12-18 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 治療用ｒｎａスイッチ組成物及び使用方法
US20140058319A1 (en) * 2012-03-20 2014-02-27 Glucago Llc Compact Device For Rapidly Mixing and Delivering Substances To a Patient
US8992469B2 (en) 2012-06-26 2015-03-31 Glucago Llc Reconstitution device
US9125995B2 (en) 2012-12-05 2015-09-08 Glucago Llc Reconstitution devices
US9345487B2 (en) 2013-02-05 2016-05-24 Path Scientific, Llc Precision bone drill and method of use
EP2851086A1 (de) 2013-09-20 2015-03-25 Sanofi Serpine: Verfahren zur therapeutischen ß-Zellen-Regeneration und Funktion
EP2769732A1 (de) 2013-02-22 2014-08-27 Sanofi Serpine: Verfahren zur therapeutischen Beta-Zellen-Regeneration und Funktion
US20160002316A1 (en) 2013-02-22 2016-01-07 Joslin Diabetes Center Serpins: methods of therapeutic beta-cell regeneration and function
EP2968886A1 (de) 2013-03-14 2016-01-20 Hallux, Inc. Verfahren zur behandlung von infektionen, krankheiten oder störungen der nägel
US9808579B2 (en) * 2013-05-08 2017-11-07 Elwha Llc Needleless injector systems, and related methods and components
US10279113B2 (en) * 2013-05-17 2019-05-07 Socpra Sciences Et Genie S.E.C. Needleless syringe and method for delivering therapeutic particles
AU2015222937B2 (en) * 2014-02-26 2017-03-30 Powder Pharmaceuticals Incorporated Device for delivering particles
WO2015171964A1 (en) * 2014-05-07 2015-11-12 Sri International Needle free injection device
US9737251B2 (en) 2014-05-28 2017-08-22 Verily Life Sciences Llc Needle-free blood draw
EP2959931A1 (de) * 2014-06-24 2015-12-30 LTS LOHMANN Therapie-Systeme AG Nadellose Injektionsvorrichtung
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3011988A1 (de) * 2014-10-22 2016-04-27 LTS LOHMANN Therapie-Systeme AG Nadellose Injektionsvorrichtung aufweisend ein Gel und eine Membran
WO2016077382A2 (en) 2014-11-11 2016-05-19 Massachusetts Eye & Ear Infirmary Conjunctivitis vaccines
WO2016100401A1 (en) 2014-12-15 2016-06-23 Dicerna Pharmaceuticals, Inc. Ligand-modified double-stranded nucleic acids
EP3277815B1 (de) 2015-04-03 2021-09-22 University of Massachusetts Oligonukleotidverbindungen zur behandlung von präeklampsie und anderen angiogenen erkrankungen
CA2980337A1 (en) 2015-04-03 2016-10-06 University Of Massachusetts Oligonucleotide compounds for targeting huntingtin mrna
EP3292206B8 (de) 2015-05-07 2022-02-09 Takeda Pharmaceutical Company Limited Glucocerebrosidase gentherapie von morbus parkinson
KR20240042548A (ko) 2015-06-03 2024-04-02 인타르시아 세라퓨틱스 인코포레이티드 임플란트 배치 및 제거 시스템들
US20160361240A1 (en) 2015-06-11 2016-12-15 The Procter & Gamble Company Apparatus and methods for modifying keratinous surfaces
CA2995110A1 (en) 2015-08-14 2017-02-23 University Of Massachusetts Bioactive conjugates for oligonucleotide delivery
JP2018535655A (ja) 2015-09-29 2018-12-06 アムジエン・インコーポレーテツド Ａｓｇｒ阻害剤
CA3005878A1 (en) 2015-11-19 2017-05-26 The Brigham And Women's Hospital, Inc. Lymphocyte antigen cd5-like (cd5l)-interleukin 12b (p40) heterodimers in immunity
US11027071B2 (en) * 2015-12-28 2021-06-08 Inovio Pharmaceuticals, Inc. Intradermal jet injection electroporation device
CA3011894A1 (en) 2016-01-31 2017-08-03 University Of Massachusetts Branched oligonucleotides
MA53353A (fr) 2016-05-16 2021-06-09 Intarcia Therapeutics Inc Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CA3033368A1 (en) 2016-08-12 2018-02-15 University Of Massachusetts Conjugated oligonucleotides
US10443055B2 (en) 2016-12-22 2019-10-15 Beth Israel Deaconess Medical Center Compounds that target MYC microRNA responsive elements for the treatment of MYC-associated cancer
EP3565580B1 (de) 2017-01-03 2024-03-06 i2o Therapeutics, Inc. Kontinuierlicher verabreichung von exenatid und co-verabreichung von acetaminophen, ethinylestradiol oder levonorgestrel
EP3664834A1 (de) 2017-08-11 2020-06-17 Dana Farber Cancer Institute, Inc. Verwendung eines botulinumtoxinmittels zur behandlung von plasmazellstörungen
US11821003B2 (en) 2017-08-14 2023-11-21 Sanford Burnham Prebys Medical Discovery Institute Cardiogenic mesoderm formation regulators
EP3703669A4 (de) 2017-11-01 2021-11-10 Dana-Farber Cancer Institute, Inc. Verfahren zur behandlung von krebs
CN112424352A (zh) 2018-05-11 2021-02-26 阿尔法阿诺麦里克公司 包括7′-5′-α-异头双环糖核苷的寡核苷酸缀合物
CN108553748A (zh) * 2018-05-11 2018-09-21 江秀秀 B超监视下体内多种细胞植入仪
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
JP2021533762A (ja) 2018-08-10 2021-12-09 ユニバーシティ・オブ・マサチューセッツUniversity Of Massachusetts Ｓｎｐを標的化する修飾オリゴヌクレオチド
EP3843845A4 (de) 2018-08-29 2022-05-11 University Of Massachusetts Hemmung von proteinkinasen zur behandlung von friedreich-ataxie
KR102199724B1 (ko) * 2018-10-05 2021-01-07 주식회사 피테크 무바늘 무통 주사 장치
BR112021012172A2 (pt) 2018-12-12 2021-08-31 Kite Pharma, Inc. Receptores de antígenos quiméricos e de célula t e métodos de uso
CN114072501A (zh) 2019-05-06 2022-02-18 马萨诸塞大学 抗c9orf72寡核苷酸及相关方法
IT201900007060A1 (it) 2019-05-21 2020-11-21 St Superiore Di Sanita Cellule tumorali ingegnerizzate e loro usi
CN110038212A (zh) * 2019-05-29 2019-07-23 徐小棠 一种呼吸内科护理给药多用装置
CN110180051B (zh) * 2019-07-13 2021-04-02 河南省中医院（河南中医药大学第二附属医院） 产科护理用清洗装置
IT201900012540A1 (it) 2019-07-22 2021-01-22 Humanitas Mirasole Spa Inibitori di CHI3L1 e loro usi
GB202105455D0 (en) 2021-04-16 2021-06-02 Ucl Business Ltd Composition
EP4359539A1 (de) 2021-06-23 2024-05-01 University Of Massachusetts Optimierte anti-flt1-oligonukleotidverbindungen zur behandlung von präeklampsie und anderen angiogenen erkrankungen
AU2022299660A1 (en) * 2021-06-24 2024-01-18 Avectas Limited Spray nozzle
GB202112471D0 (en) 2021-09-01 2021-10-13 King S College London Microna systems
WO2024052732A1 (en) * 2022-09-07 2024-03-14 Particle Vaccine Canada Ltd. Method and apparatus for epidermal delivery of powdered medicaments

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE170094C (de)
US1300654A (en) 1919-01-30 1919-04-15 William H Rose Dry-spraying machine.
US2151418A (en) * 1937-05-12 1939-03-21 Scott & Bowne Powder applicator
US2147158A (en) 1937-09-28 1939-02-14 Goldenthal Philip Powder insufflator
US2307986A (en) 1940-02-15 1943-01-12 Bolte Insufflator
US2605763A (en) * 1948-01-31 1952-08-05 Becton Dickinson Co Injection device
GB677523A (en) * 1948-04-13 1952-08-20 Becton Dickinson Co Discharge structure for hypodermic injection device
US2478715A (en) 1948-07-14 1949-08-09 Vilbiss Co Powder blower
US2594093A (en) 1949-02-05 1952-04-22 Armour & Co Powder container
US2470298A (en) 1949-02-07 1949-05-17 Abbott Lab Powdered medicine dispenser
DE1047385B (de) * 1952-03-08 1958-12-24 Armour & Co Puderzerstaeuber mit einem auswechselbaren Puderbehaelter
US3216562A (en) 1963-06-13 1965-11-09 Driaire Inc Easy-open capsule
IL28680A (en) 1966-12-16 1971-12-29 American Home Prod Stabilized aqueous suspensions of benzathine penicillin
US3674028A (en) * 1969-06-04 1972-07-04 Ims Ltd Multi-mix
US3736933A (en) * 1970-12-02 1973-06-05 B Szabo Burstable seamed hypodermic applicators
US3788315A (en) * 1971-04-20 1974-01-29 S Laurens Disposable cutaneous transjector
US3914573A (en) * 1971-05-17 1975-10-21 Geotel Inc Coating heat softened particles by projection in a plasma stream of Mach 1 to Mach 3 velocity
US3853125A (en) * 1971-10-05 1974-12-10 W Clark Disposable needleless injector
US3782380A (en) * 1973-01-04 1974-01-01 Gaast H V D Medicament injecting device
US4069819A (en) * 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
US3946732A (en) * 1973-08-08 1976-03-30 Ampoules, Inc. Two-chamber mixing syringe
US3967761A (en) 1974-04-08 1976-07-06 Southwest Research Institute System for injecting particulate material into the combustion chamber of a repetitive combustion coating apparatus
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
US3982605A (en) * 1975-05-05 1976-09-28 The Carborundum Company Nozzle noise silencer
FR2360031A1 (fr) * 1976-07-27 1978-02-24 Klein Max Dispositif distributeur silencieux d'un jet de gaz et application au diagnostic medical
JPS602489B2 (ja) * 1977-05-02 1985-01-22 株式会社豊田中央研究所 低騒音用圧力流体放出装置
AU521982B2 (en) * 1978-06-16 1982-05-13 Phares Pharmaceutical Research N.V. Pharmaceuticals with urea incuusion compounds
US4226236A (en) * 1979-05-07 1980-10-07 Abbott Laboratories Prefilled, vented two-compartment syringe
FI79651C (fi) 1982-10-08 1990-02-12 Glaxo Group Ltd Doseringsanordning foer medicin.
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
US4515586A (en) 1982-11-30 1985-05-07 Abbott Laboratories Powder syringe mixing system
US4652261A (en) * 1984-06-22 1987-03-24 Regents Of The University Of Minnesota Drug-injection animal capture collar
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5100792A (en) * 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US4596556A (en) * 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4811731A (en) 1985-07-30 1989-03-14 Glaxo Group Limited Devices for administering medicaments to patients
DK179286D0 (da) 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
USRE33801E (en) 1986-05-09 1992-01-21 Dentsply Research & Development Corp. Mixing and discharge capsule
US5120657A (en) 1986-12-05 1992-06-09 Agracetus, Inc. Apparatus for genetic transformation
IN170021B (de) * 1987-05-26 1992-01-25 Deita Freyberg Gmbh
GB2206794A (en) * 1987-07-14 1989-01-18 Richard Kiteley Power Syringe
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5179022A (en) * 1988-02-29 1993-01-12 E. I. Du Pont De Nemours & Co. Biolistic apparatus for delivering substances into cells and tissues in a non-lethal manner
BR8801952A (pt) * 1988-04-22 1989-11-14 Sergio Landau Capsula descartavel,nao re-utilizavel,contendo dose individual de vacina a ser injetada hipodermicamente,sem agulha,com aparelho injetor a pressao
FR2638359A1 (fr) * 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
JPH04504858A (ja) * 1989-04-20 1992-08-27 マウント　シナイ　スクール　オブ　メディスン　オブ　ザ　シティー　ユニバーシティー　オブ　ニューヨーク 肝臓特異性インシュリン類似体
US5239991A (en) 1989-06-21 1993-08-31 Fisons Plc Disposable powder medicament inhalation device with peel-off cover
HU200699B (en) * 1989-07-05 1990-08-28 Gyula Erdelyi Neddleless hypodermic syringe particularly for blinds and poor-sighted persons
GB8918879D0 (en) * 1989-08-18 1989-09-27 Danbiosyst Uk Pharmaceutical compositions
US5064413A (en) * 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
AU7558991A (en) * 1990-03-15 1991-10-10 United States Of America, As Represented By The Secretary Of The Army, The Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
US5062830A (en) * 1990-04-04 1991-11-05 Derata Corporation Dry disposable nozzle assembly for medical jet injector
GB9011588D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
US5204253A (en) * 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
IT1243344B (it) 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
GB9016789D0 (en) * 1990-07-31 1990-09-12 Lilly Industries Ltd Medicament administering devices
WO1992004439A1 (en) * 1990-08-30 1992-03-19 Brian John Bellhouse Ballistic apparatus
US5042472A (en) 1990-10-15 1991-08-27 Merck & Co., Inc. Powder inhaler device
US5188615A (en) 1990-11-19 1993-02-23 Habley Medical Technology Corp. Mixing vial
US5046618A (en) 1990-11-19 1991-09-10 R. P. Scherer Corporation Child-resistant blister pack
DK288590D0 (da) * 1990-12-04 1990-12-04 Michael Morris Blandings/oploesnings-sproejte til cytostatika for medicinsk behandling af cancer patienter
GB9027422D0 (en) * 1990-12-18 1991-02-06 Scras Osmotically driven infusion device
US5360410A (en) 1991-01-16 1994-11-01 Senetek Plc Safety syringe for mixing two-component medicaments
GB9100950D0 (en) * 1991-01-16 1991-02-27 Dunne Miller Weston Ltd Metered dose atomising and delivery device
US5492112A (en) 1991-05-20 1996-02-20 Dura Pharmaceuticals, Inc. Dry powder inhaler
US5102388A (en) 1991-07-15 1992-04-07 Richmond John E Sequential delivery syringe
GB9118204D0 (en) * 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
EP0558879B1 (de) 1992-03-04 1997-05-14 Astra Aktiebolag Wegwerfinhalator
JP3166123B2 (ja) 1992-09-09 2001-05-14 フアイソンズ・ピーエルシー 薬剤パッケージング
TW360548B (en) * 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
US5349947A (en) * 1993-07-15 1994-09-27 Newhouse Michael T Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow
US5415162A (en) 1994-01-18 1995-05-16 Glaxo Inc. Multi-dose dry powder inhalation device
NZ279995A (en) 1994-01-21 1998-04-27 Powderject Vaccines Inc Gas driven gene delivery instrument with a conical exit nozzle and a cartridge with an arcuate, linear passage
US5483954A (en) 1994-06-10 1996-01-16 Mecikalski; Mark B. Inhaler and medicated package
JP3320261B2 (ja) * 1995-06-01 2002-09-03 株式会社ユニシアジェックス 吸入式投薬器

Also Published As

Publication number Publication date
JP3260375B2 (ja) 2002-02-25
KR100332147B1 (ko) 2002-08-14
UA41360C2 (uk) 2001-09-17
NZ263606A (en) 1997-08-22
HU216308B (hu) 1999-06-28
FI954788A (fi) 1995-10-06
EP0951917A3 (de) 2000-01-05
BG100047A (bg) 1996-04-30
LV11833B (en) 1997-12-20
HUT73516A (en) 1996-08-28
US20070299390A1 (en) 2007-12-27
ES2267106T3 (es) 2007-03-01
EP0734737A3 (de) 1997-03-12
CZ260895A3 (en) 1996-05-15
EP0951917A2 (de) 1999-10-27
EP1637173B1 (de) 2014-05-21
JP2002179557A (ja) 2002-06-26
AU6435194A (en) 1994-11-08
BG61993B1 (bg) 1998-12-30
EP0734737B1 (de) 2006-06-07
GR3022939T3 (en) 1997-06-30
DE69401651D1 (de) 1997-03-13
US7942846B2 (en) 2011-05-17
NO953994L (no) 1995-10-06
JP4430636B2 (ja) 2010-03-10
US20020188248A1 (en) 2002-12-12
SI0693119T1 (en) 1997-10-31
US6168587B1 (en) 2001-01-02
CN1109102C (zh) 2003-05-21
ATE329006T1 (de) 2006-06-15
ES2098131T3 (es) 1997-04-16
DE69401651T2 (de) 1997-05-15
EP0693119A1 (de) 1996-01-24
ATE148497T1 (de) 1997-02-15
PL174974B1 (pl) 1998-10-30
PT734737E (pt) 2006-09-29
SK283855B6 (sk) 2004-03-02
HK1000351A1 (en) 1998-03-06
CA2159452A1 (en) 1994-10-27
DE69434760T2 (de) 2007-05-16
SK124895A3 (en) 1997-01-08
BR9406455A (pt) 1996-01-02
FI954788A0 (fi) 1995-10-06
RO118569B1 (ro) 2003-07-30
SI0734737T1 (sl) 2006-10-31
AU674742B2 (en) 1997-01-09
EP1637173A3 (de) 2007-09-05
LV11833A (lv) 1997-08-20
HU9502911D0 (en) 1995-12-28
PL311005A1 (en) 1996-01-22
TW360548B (en) 1999-06-11
CN1120852A (zh) 1996-04-17
RU2129021C1 (ru) 1999-04-20
JPH08509604A (ja) 1996-10-15
FI120671B (fi) 2010-01-29
HU228144B1 (en) 2012-12-28
DK0693119T3 (da) 1997-07-28
CA2159452C (en) 2000-11-21
TW404844B (en) 2000-09-11
US6881200B2 (en) 2005-04-19
US7618394B2 (en) 2009-11-17
WO1994024263A1 (en) 1994-10-27
NO953994D0 (no) 1995-10-06
TJ248B (en) 1999-12-23
EP1637173A2 (de) 2006-03-22
CZ290476B6 (cs) 2002-07-17
NO314570B1 (no) 2003-04-14
EP0693119B1 (de) 1997-01-29
US20050165348A1 (en) 2005-07-28
EP0734737A2 (de) 1996-10-02
OA10234A (en) 1997-10-07
JP2006320737A (ja) 2006-11-30
HU9802714D0 (en) 1999-01-28
US5630796A (en) 1997-05-20
DK0734737T3 (da) 2006-10-09
JP2007051160A (ja) 2007-03-01

Similar Documents

Publication Publication Date Title
DE69434760D1 (de) Teilchenverabreichung von therapeutischen Mitteln im pulverisierten Zustand
UA32541C2 (uk) Пристрій інжектора рідини, спосіб введення рідкого лікарського засобу
ATE189403T1 (de) Vorrichtung zum verabreichen von pharmazeutischen substanzen
ES2012256A6 (es) Un conector y para usarse en un procedimiento de angioplastia.
WO2001003757A3 (en) Medical fluid delivery system
DE69432476T2 (de) Vorgefüllte fluidspritze
EP0850648A3 (de) Zusammensetzungen aus einer thrombolytisch wirkende Substanz und Antikoagulantien, und ihre Verwendungen
JPS52130922A (en) Remedy for cerebral blood flow disorders containing coenzyme-q as main ingredient
AU5239000A (en) Needleless syringe
ATE75624T1 (de) Entlueftetes nadelanschlussstueck.
GEP19991876B (en) Needleless Syringe, Product Used in Syringe and Therapeutical Method for Treating by Syringe
AU3605995A (en) The use of needle-free pressure-actuated injection devices for the administration of active substances to plants
DE69306118D1 (de) Onconase und cisplatin, melphalan und adriamycin enthaltende arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition